| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/09/2013 | US8415105 Method of detecting pathogenic Legionella strains |
| 04/09/2013 | US8415104 Heat flow polymerase chain reaction systems and methods |
| 04/09/2013 | US8415103 Microfluidic cartridge |
| 04/09/2013 | US8415102 Methods and computer systems for identifying target-specific sequences for use in nanoreporters |
| 04/09/2013 | US8415101 Digital optical chemistry micromirror imager |
| 04/09/2013 | US8415100 Methods and compositions for detecting gastrointestinal and other cancers |
| 04/09/2013 | US8415099 Efficient base determination in sequencing reactions |
| 04/09/2013 | US8415098 Method for isolating specific genomic regions |
| 04/09/2013 | US8415097 Tumor suppressor gene, p47ING3 |
| 04/09/2013 | US8415096 Micro-RNAs modulating immunity and inflammation |
| 04/09/2013 | US8415095 Use of nucleoside derivatives comprising a citrate group for the production of antibodies having an affinity for triphosphorylated nucleosides |
| 04/09/2013 | US8414900 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 04/09/2013 | US8414898 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 04/09/2013 | US8414895 Tweak receptor |
| 04/09/2013 | US8414761 Biosensor |
| 04/09/2013 | US8414760 Biosensor electrode mediators for regeneration of cofactors |
| 04/09/2013 | US8414750 Subcutaneous glucose electrode |
| 04/09/2013 | US8414749 Subcutaneous glucose electrode |
| 04/09/2013 | DE202012100019U1 T-Zellen-Frequenz T cell frequency |
| 04/09/2013 | CA2680739C Method for evaluation of tissue preservation solution |
| 04/09/2013 | CA2667767C Biosensor electrode mediators for regeneration of cofactors |
| 04/09/2013 | CA2515734C Signal amplification method for detecting expressed gene |
| 04/09/2013 | CA2486618C Methods for the in vitro culture of sporozoea sp. and uses thereof |
| 04/09/2013 | CA2425208C Rna aptamers and methods for identifying the same |
| 04/09/2013 | CA2421963C Directed evolution method |
| 04/09/2013 | CA2391739C Site-directed mutagenesis of escherichia coli phytase |
| 04/09/2013 | CA2359803C Udp-glucose epimerases |
| 04/09/2013 | CA2328069C Automated analyzer and associated methods for performing nucleic acid-based assays |
| 04/09/2013 | CA2288430C Crsp protein (cysteine-rich secreted proteins), nucleic acid molecules encoding them and uses therefor |
| 04/09/2013 | CA2274319C Methods and compositions for polypeptide engineering |
| 04/07/2013 | CA2878568A1 Methods for dynamic visualization of clinical parameters over time |
| 04/05/2013 | CA2758821A1 Compositions, methods and kits to detect adenovirus nucleic acids |
| 04/04/2013 | WO2013049822A2 Diagnostic method for determining animals persistently infected (pi) with bovine viral diarrhea virus (bvdv) |
| 04/04/2013 | WO2013049750A1 Mutations in sf3b1 and chronic lymphocytic leukemia |
| 04/04/2013 | WO2013049702A2 Systems and methods for biological analysis |
| 04/04/2013 | WO2013049613A1 Hydrolysis probes |
| 04/04/2013 | WO2013049525A1 Packaging or other materials comprising a biosensor and methods of their use |
| 04/04/2013 | WO2013049508A1 Compositions and methods for toxigenicity testing |
| 04/04/2013 | WO2013049504A1 Dna sample preparation and sequencing |
| 04/04/2013 | WO2013049489A1 Sequences and their use for detection and characterization of stec bacteria |
| 04/04/2013 | WO2013049443A1 Methods and systems for visualizing and evaluating data |
| 04/04/2013 | WO2013049437A2 Molecular targets and methods for formulation screening and preservative efficacy testing |
| 04/04/2013 | WO2013049258A1 Systems and methods for predicting response to minoxidil for the treatment of androgenetic alopecia |
| 04/04/2013 | WO2013049231A1 Methods of co-detecting mrna and small non-coding rna |
| 04/04/2013 | WO2013049152A2 Methods for evaluating lung cancer status |
| 04/04/2013 | WO2013049038A1 Assessment of risk of local recurrence of cancer using telomere health |
| 04/04/2013 | WO2013048952A1 Methods and compositions for detecting infections |
| 04/04/2013 | WO2013048583A2 Detection of methicillin-resistant staphylococcus aureus |
| 04/04/2013 | WO2013048558A2 Methods of therapeutic monitoring of nitrogen scavenging drugs |
| 04/04/2013 | WO2013047912A1 Method for evaluating drug sensitivity and susceptibility to diseases by analyzing gene for protein capable of binding to cyclic-amp-responsive sequence |
| 04/04/2013 | WO2013047910A1 Method for evaluating degree of cancerization |
| 04/04/2013 | WO2013047785A1 Method for detecting protein that interacts with target substance |
| 04/04/2013 | WO2013047773A1 Method for inducing orexin neuron |
| 04/04/2013 | WO2013047736A1 Nucleic acid encoding self-incompatibility regulation factor |
| 04/04/2013 | WO2013047720A1 Method for inducing hepatocellular variation, and production method for chimeric non-human animal having humanized liver |
| 04/04/2013 | WO2013047677A1 Linear amplification method for trace dna fragment |
| 04/04/2013 | WO2013047428A1 Method for producing mature mast cell |
| 04/04/2013 | WO2013046980A1 Cell sorter and cell sorting method |
| 04/04/2013 | WO2013046960A1 Nucleic acid construct for use in screening for peptide antibody, and screening method using same |
| 04/04/2013 | WO2013046116A1 Apparatus for the processing of single molecules |
| 04/04/2013 | WO2013046033A1 Hybridization compositions and methods using formamide |
| 04/04/2013 | WO2013045939A1 Continuous extension and deblocking in reactions for nucleic acid synthesis and sequencing |
| 04/04/2013 | WO2013045908A1 Mutational analysis of jak2 |
| 04/04/2013 | WO2013045902A1 Predicting thiopurine hypermethylation |
| 04/04/2013 | WO2013045854A1 Fluorogenic peptidase substrate |
| 04/04/2013 | WO2013045700A1 Method for the spatial arrangement of sample fragments for amplification and immobilization for further derivatizations |
| 04/04/2013 | WO2013045505A1 Biomarkers for raas combination therapy |
| 04/04/2013 | WO2013045487A1 Azo mediators |
| 04/04/2013 | WO2013045464A1 Cdna biomarkers in whole blood for colorectal cancer assessment |
| 04/04/2013 | WO2013045458A1 Stabilisation and isolation of extracellular nucleic acids |
| 04/04/2013 | WO2013045457A1 Stabilisation and isolation of extracellular nucleic acids |
| 04/04/2013 | WO2013045417A1 Sequence-specific analysis of nucleic acids |
| 04/04/2013 | WO2013044792A1 Nicotinamide adenine dinucleotide gene encoding fluorescent probe, preparation method therefor and application thereof |
| 04/04/2013 | WO2013044575A1 Elisa kit for detecting polypeptide marker antigen |
| 04/04/2013 | WO2013044464A1 Fluorescence generation device |
| 04/04/2013 | WO2013044392A1 Methods and apparatus for flow-controlled wetting |
| 04/04/2013 | WO2013044391A1 Assay for inhibitors of cip/kip protein degradation |
| 04/04/2013 | WO2013044354A1 Method and system for genetic trait search based on the phenotype and the genome of a human subject |
| 04/04/2013 | WO2013044336A1 Oligonucleotides, use, method and kit for detecting the contamination of samples by yeasts |
| 04/04/2013 | WO2013022995A3 Biomarker compositions and methods |
| 04/04/2013 | WO2013022203A9 Method for detecting nucleic acid using intercalator-conjugated metal nanoparticles |
| 04/04/2013 | WO2013016693A3 Near-infrared light-activated proteins |
| 04/04/2013 | WO2013016529A3 Disk diffusion assay for oritavancin |
| 04/04/2013 | WO2013016340A3 Systems, devices, and methods for automated characterization of a nucleic acid molecule |
| 04/04/2013 | WO2013011153A3 Method for the prognosis and treatment of metastasis in breast cancer |
| 04/04/2013 | WO2013010225A8 Enzymes for degrading organophosphates |
| 04/04/2013 | WO2013009967A3 Identifying affinity-matured human antibodies |
| 04/04/2013 | WO2013006278A3 Identity elucidation of unknown metabolites |
| 04/04/2013 | WO2013003583A3 Somatic mutations in atrx in brain cancer |
| 04/04/2013 | WO2012174203A3 Methods and kits for the detection and treatment of recurring prostate cancer |
| 04/04/2013 | WO2012173809A3 Method of identifying de novo copy number variants (cnv) using mz twins discordant for attention problems/disorders |
| 04/04/2013 | WO2012170614A3 Dna methylation markers in non-small cell lung cancer and methods of using the same |
| 04/04/2013 | WO2012167218A3 Device and method for identifying microbes and counting microbes and determining antimicrobial sensitivity |
| 04/04/2013 | WO2012162514A3 Epigenetic co-repressors of the gamma-globin gene and methods of using same |
| 04/04/2013 | WO2012129395A3 Diagnosis and treatment of prostate cancer |
| 04/04/2013 | WO2012103522A3 Materials and methods for identifying patients susceptible to developing taxane induced neuropthy |
| 04/04/2013 | WO2012074855A3 Methods of identifying a cellular nascent rna transcript |
| 04/04/2013 | WO2011140464A9 MASS SPECTROMETRY ASSAY FOR elF4E AND elF4E REGULON ACTIVITY |
| 04/04/2013 | US20130085262 Novel surface antigen |
| 04/04/2013 | US20130085260 Method for the identification of t cell epitopes |